Skip to main content
. 2018;19(2):337–342. doi: 10.22034/APJCP.2018.19.2.337

Table 5.

Distribution of Parvovirus B19 Virological Markers Among Studied Subjects

Patients with acute myeloid leukemia Patients under chemotherapy for acute myeloid leukemia Control group
(n=32) (n=16) (n=60) p value
IgM 12 (37.5%) 8 (50%) 2 (3.3%) 0.0001
PCR 16 (50%) 8 (50%) 0 (0%) 0.0001
IgG 11 (34.4%) 8 (50%) 7 (11.7%) 0.0001